Spinal nerve stimulation for chemo-related nerve pain
Part of Brain & nervous system, Cancer, Pain clinical trials.
This study tests a spinal cord stimulator—a device that sends mild electrical pulses to the spine—to see if it can reduce severe nerve pain that lasts more than 6 months after chemotherapy. It is for people who have tried other treatments like duloxetine but still have significant pain.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have nerve pain caused by chemotherapy (specifically platinum or taxane drugs).
- Your pain is at least a 4 out of 10 on a pain scale and has lasted more than 6 months after chemo ended.
- You have tried duloxetine (a nerve pain medicine) and it didn't work well enough.
- You are 18 years or older.
- You do not have certain recent chemotherapy drugs (vincristine, thalidomide, bortezomib, or eribulin) in the last year.
- You do not have a low platelet count, active infection, or a spinal problem that would block the device placement.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether spinal cord stimulation can reduce pain and improve quality of life in people with long-lasting nerve pain from chemotherapy (CIPN). You must already have tried at least two nerve-pain medicines and still have significant pain, and you must have had a successful spinal cord stimulator test before joining.
This study tests whether a small device that sends gentle electrical pulses to nerves in your leg can relieve pain caused by chemotherapy. If you have ongoing nerve pain in your legs from past chemo, this treatment might offer a new way to manage it.
This study tests whether a gentle, non-invasive brain stimulation (over the motor cortex) can help relieve pain caused by nerve damage from chemotherapy. It is for people who have completed cancer treatment at least 3 months ago and have ongoing painful neuropathy.
This study tests whether a gentle electrical current applied to the scalp (called transcranial direct current stimulation, or tDCS) can help reduce numbness, tingling, or pain caused by chemotherapy. It is for people who have completed active cancer treatment.
This trial studies whether a skin-applied, acupuncture-like electrical treatment can reduce ongoing nerve pain (chemotherapy-induced peripheral neuropathy) after breast cancer chemotherapy. It may help if your nerve symptoms have not improved after finishing chemo.
This trial tests a small device you wear on your ear to see if it can reduce nerve pain caused by chemotherapy (CIPN). You use it yourself at home, and it may help with the tingling, numbness, or burning in your hands and feet.
Hear when a new Chemotherapy-induced Peripheral Neuropathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.